A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

NCT03831607 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: KHK7791

Sponsor

Kyowa Kirin Co., Ltd.